Marshall Wace, LLP Lexicon Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 574,150 shares of LXRX stock, worth $465,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

574,150

Previous 1,190,448 51.77%

Holding current value

$465,061

Previous $2 Million 54.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.39 $930,609 - $1.47 Million	-616,298 Reduced 51.77%	574,150 $901,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $1.06 Million - $1.58 Million	691,276 Added 138.48%	1,190,448 $2 Million
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $648,923 - $1.79 Million	499,172 New	499,172 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $269,367 - $437,251	125,287 New	125,287 $286,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $3.67 $295,729 - $1.03 Million	-281,647 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $943,119 - $1.38 Million	-654,944 Reduced 69.93%	281,647 $406,000
Q2 2020 Aug 13, 2020	SELL	$1.75 - $2.3 $715,783 - $940,743	-409,019 Reduced 30.4%	936,591 $1.87 Million
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $890,427 - $2.12 Million	494,682 Added 58.13%	1,345,610 $2.62 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $2.69 Million - $4.38 Million	850,928 New	850,928 $3.53 Million
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $1.15 Million - $2.1 Million	-264,139 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $1.41 Million - $2.42 Million	229,876 Added 670.92%	264,139 $1.75 Million
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $6.36 Million - $8.05 Million	-616,555 Reduced 94.74%	34,263 $366,000
Q2 2018 Aug 14, 2018	SELL	$7.8 - $13.69 $668,670 - $1.17 Million	-85,727 Reduced 11.64%	650,818 $7.81 Million
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $5.79 Million - $8.39 Million	736,545 New	736,545 $6.31 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $153M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Lexicon Pharmaceuticals, Inc. Transaction History